强生:Inlexzo联合Cetrelimab在计划接受根治性膀胱切除术的肌侵袭性膀胱癌患者中取得强劲的术前结果

美股速递
Oct 20, 2025

强生:Inlexzo联合Cetrelimab在计划接受根治性膀胱切除术的肌侵袭性膀胱癌患者中取得强劲的术前结果

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10